|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/38 | |
| A61K 39/395 | |||
| A61P 7/04 |
| (11) | Patento numeris | 2379600 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09793543.1 |
| Europos patento paraiškos padavimo data | 2009-12-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-10-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-01-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2009/067598 |
| Data | 2009-12-18 |
| (87) | Numeris | WO 2010/072691 |
| Data | 2010-07-01 |
| (30) | Numeris | Data | Šalis |
| 08172520 | 2008-12-22 | EP |
| (72) |
HILDEN, Ida, DK
KROGH, Berit Olsen, DK
CLAUSEN, Jes Thorn, DK
OLSEN, Ole Hvilsted, DK
BREINHOLT, Jens, DK
LAURITZEN, Brian, DK
S RENSEN, Brit Binow, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR |
| ANTIBODIES AGAINST TISSUE FACTOR PATHWAY INHIBITOR |